Abstract
Purpose
A systematic review of the validity, reliability and sensitivity of the Short Form (SF) health survey measures among breast cancer survivors.
Methods
We searched a number of databases for peer-reviewed papers. The methodological quality of the papers was assessed using the COnsenus-based Standards for the selection of health Measurement INstruments (COSMIN).
Results
The review identified seven papers that assessed the psychometric properties of the SF-36 (n = 5), partial SF-36 (n = 1) and SF-12 (n = 1) among breast cancer survivors. Internal consistency scores for the SF measures ranged from acceptable to good across a range of language and ethnic sub-groups. The SF-36 demonstrated good convergent validity with respective subscales of the Functional Assessment of Cancer Treatment—General scale and two lymphedema-specific measures. Divergent validity between the SF-36 and Lymph-ICF was modest. The SF-36 demonstrated good factor structure in the total breast cancer survivor study samples. However, the factor structure appeared to differ between specific language and ethnic sub-groups. The SF-36 discriminated between survivors who reported or did not report symptoms on the Breast Cancer Prevention Trial Symptom Checklist and SF-36 physical sub-scales, but not mental sub-scales, discriminated between survivors with or without lymphedema. Methodological quality scores varied between and within papers.
Conclusion
Short Form measures appear to provide a reliable and valid indication of general health status among breast cancer survivors though the limited data suggests that particular caution is required when interpreting scores provided by non-English language groups. Further research is required to test the sensitivity or responsiveness of the measure.
Similar content being viewed by others
References
Coleman, M. P., Forman, D., Bryant, H., Butler, J., Rachet, B., Nur, U., et al. (2011). Cancer survival in Australia, Canada, Denmark, Norway, Sweden and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. The Lancet, 377, 127–138.
Treanor, C., & Donnelly, M. (2014). Late effects of cancer and cancer treatment—A rapid review. Journal of Supportive Oncology, 12, 137–148.
Mols, F., Vingerhoets, J. M., Coebergh, J. W., & van de Poll-Franse, L. V. (2005). Quality of life among long-term breast cancer survivors: A systematic review. European Journal of Cancer, 41, 2613–2619.
Treanor, C., Santin, O., Mills, M., & Donnelly, M. (2013). Cancer survivors with late effects: Their health status, care needs and service utilisation. Psycho-Oncology, 22, 2428–2435.
Department of Health, Macmillan Cancer Support & NHS Improvement. (2010). The national cancer survivorship initiative vision. London: Department of Health.
Mokkink, L. B., Terwee, C. B., Patrick, D. L., Alonso, J., Stratford, P. W., Knol, D. L., et al. (2010). The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: An international Delphi study. Quality of Life Research, 19, 539–549.
Mokkink, L. B., Terwee, C. B., Patrick, D. L., Alonso, J., Stratford, P. W., Knol, D. L., et al. (2010). International consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes: Results of the COSMIN study. Journal of Clinical Epidemiology, 63, 737–745.
Terwee, C. B., Mokkink, L. B., Knol, D. L., Ostelo, R. W. J. G., Bouter, L. M., & de Vet, H. C. W. (2012). Rating the methodological quality in systematic reviews of studies on measurement properties: A scoring system for the COSMIN checklist. Quality of Life Research, 21, 651–657.
Mokkink, L. B., Terwee, C. B., Gibbons, E., Stratford, P. W., Alonso, J., Patrick, D. L., et al. (2010). Inter-rater agreement and reliability of the COSMIN (COnsensus-based Standards for the selection of health status Measurement INstruments) Checklist. BMC Medical Research Methodology, 10, 82.
Ashing-Giwa, K. T., Padilla, G. V., Tejero, J. S., & Kim, J. (2004). Breast cancer survivorship in a multiethnic sample. Challenges in recruitment and measurement. Cancer, 101, 450–465.
Wilson, R. W., Hutson, L. M., & VanStry, D. (2005). Comparison of 2 quality-of-life questionnaires in women treated for breast cancer: The RAND 36-Item Health Survey and the Functional Living Index-Cancer. Physical Therapy, 85, 851–860.
Ashing-Giwa, K., & Rosales, M. (2013). A cross-cultural validation of patient-reported outcomes measures: A study of breast cancer survivors. Quality of Life Research, 22, 295–308.
Ashing-Giwa, K., Lam, C. N., & Xie, B. (2013). Assessing health-related quality of life of Chinese-American breast cancer survivors: A measurement validation study. Psycho-Oncology, 22, 704–707.
Devoogdt, N., van Kampen, M., Geraerts, I., Coremans, T., & Christiaens, M. (2011). Lymphoedema Functioning, Disability and Health Questionnaire (Lymph-ICF): Reliability and validity. Physical Therapy, 91, 944–957.
Viehoff, P. B., van Genderen, F. R., & Wittink, H. (2008). Upper limb lymphedema 27 (ULL27) Dutch translation and validation of an illness-specific health-related quality of life questionnaire for patients with upper limb lymphedema. Lymphology, 41, 131–138.
Terhorst, L., Blair-Belansky, H., Moore, P. J., & Bender, C. (2011). Evaluation of the psychometric properties of the BCPT Symptom Checklist with a sample of breast cancer patients before and after adjuvant therapy. Psycho-Oncology, 20, 961–968.
Reulen, R. C., Zeegers, M. P., Jenkinson, C., Lancashire, E. R., Winter, D. L., Jenney, M. E., et al. (2006). The use of the SF-36 questionnaire in adult survivors of childhood cancer: Evaluation of data quality, score reliability, and scaling assumptions. Health and Quality of Life Outcomes, 4, 77.
Ryan, M., Stainton, C. M., Jaconelli, C., Watts, S., MacKenzie, P., & Mansberg, T. (2003). The experience of lower limb lymphedema for women after treatment for gynecologic cancer. Oncology Nursing Forum, 30, 417–423.
Bower, T. E., Ganz, P. A., Desmond, K. A., Rowland, J. H., Meyerowitz, B. E., & Belin, T. R. (2000). Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life. Journal of Clinical Oncology, 18, 743–753.
Forsythe, L. P., Alfano, C. M., George, S. M., McTiernan, A., Baumgartner, K. B., Bernstein, L., et al. (2013). Pain in long-term breast cancer survivors: The role of body mass index, physical activity, and sedentary behavior. Breast Cancer Research and Treatment, 137, 617–630.
Minton, O., & Stone, P. (2009). A systematic review of the scales used for the measurement of cancer-related fatigue (CRF). Annals of Oncology, 20, 17–25.
Kim, S. H., Son, B. H., Hwang, S. Y., Han, W., Yang, J., Lee, S., et al. (2008). Fatigue and depression in disease-free breast cancer survivors: Prevalence, correlates, and association with quality of life. Journal of Pain and Symptom Management, 35, 644–655.
Stewart, A. L., & Nápoles-Springer, A. (2000). Health-related quality-of-life assessments in diverse population groups in the United States. Medical Care, 38, 102–124.
Mokkink, L. B., Terwee, C. B., Patrick, D .L., Alonso, J., Stratford, P. W., Knol, D. L. et al. (2012). COSMIN Checklist Manual. http://www.cosmin.nl/images/upload/files/COSMIN%20checklist%20manual%20v9.pdf. Accessed on 1 Dec 2013.
Schwartz, C. E., Bode, R., Repucci, N., Becker, N., Sprangers, M. A. G., & Fayers, P. M. (2006). The clinical significance of adaptation to changing health: A meta-analysis of response shift. Quality of Life Research, 15, 1533–1550.
Nesvold, I.-L., Fossä, S. D., Holm, I., et al. (2010). Arm/shoulder problems in breast cancer survivors are associated with reduced health and poorer physical quality of life. Acta Oncologica, 49, 347–353.
Acknowledgments
CT received funding support from UKCRC Centre of Excellence for Public Health, Queen’s University Belfast to undertake the review.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Treanor, C., Donnelly, M. A methodological review of the Short Form Health Survey 36 (SF-36) and its derivatives among breast cancer survivors. Qual Life Res 24, 339–362 (2015). https://doi.org/10.1007/s11136-014-0785-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-014-0785-6